Benzinga | Jun 14, 2021 01:22PM EDT

Karyopharm Therapeutics Posts Study Titled 'Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma' To ClinicalTrials.Gov Site

https://clinicaltrials.gov/ct2/show/NCT04925193